Conformational toxicity and sporadic conformational diseases

被引:12
|
作者
Reiss, C [1 ]
Lesnik, T
Parvez, H
Parvez, S
Ehrlich, R
机构
[1] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France
[2] Inst Alfred Fessard, CNRS, F-91198 Gif Sur Yvette, France
[3] Univ Republ, Fac Ciencias, Secc Bioquim, Montevideo 11400, Uruguay
关键词
conformational toxicity; conformational diseases; protein misfolding;
D O I
10.1016/S0300-483X(00)00308-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Spontaneous, so-called 'conformational' diseases, specially of the neurodegenerative type like Alzheimer's, are linked to certain protein types which have the normal amino-acid sequence but are misfolded and accumulate due to resistance to proteolysis. In the case of prion diseases, the 'protein only' hypothesis assumes that the misconformation of a native protein could be initiated upon interaction with a sister-protein already in the misfolded stare. There is an alternative to this sister protein contamination scheme, which assumes that the misconformation is acquired upon protein synthesis, that is de novo. Misfoldling and resistance to proteolysis could result from defects responsible for shortage or inactivity of the cellular factors in charge of protein folding and degradation. The defects could have a genetic origin (the gene of the faulty factor involved could have been mutated, or control and regulation of its expression could have been altered, etc.). Alternatively, the cell's actual biosynthetic and/or proteolytic resources could have become overloaded and unavailable, due to unscheduled mass-production of proteins resulting from unscheduled cell growth or proliferation, cell stress, etc. Xenobiotics, active for instance as endocrine proliferators, stressors, or inducing copious, unscheduled gene expression, etc. could give rise to shortage of cellular factors necessary for the production of native proteins and for proteolysis. Alternatively, xenobiotics could alter expression or activity of some of these factors. In both cases, the xenobiotic could be a 'conformational toxicant' by inducing misfolding of selected proteins. The xenobiotic could trigger some conformational disease if it targets a specific protein and tissue. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [1] Conformational Diseases
    Zatta, Paolo
    CURRENT ALZHEIMER RESEARCH, 2008, 5 (06) : 499 - 499
  • [2] Immunotherapy for conformational diseases
    Sigurdsson, Einar M.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) : 2569 - 2585
  • [3] Cell toxicity and conformational disease
    Carrell, RW
    TRENDS IN CELL BIOLOGY, 2005, 15 (11) : 574 - 580
  • [4] Familial conformational diseases and dementias
    Crowther, DC
    HUMAN MUTATION, 2002, 20 (01) : 1 - 14
  • [5] Conformational diseases (neurological aspects)
    Zavalishin, IA
    Zakharova, MN
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2003, 103 (01): : 54 - 60
  • [6] Conformational diseases: Looking into the eyes
    Surguchev, Alexei
    Surguchov, Andrei
    BRAIN RESEARCH BULLETIN, 2010, 81 (01) : 12 - 24
  • [7] Molecular biology of conformational diseases
    Reiss, C
    Lesnik, T
    Parvez, H
    Parvez, S
    Ehrlich, R
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 521 - 524
  • [8] Conformational biosensor for diagnosis of prion diseases
    Tcherkasskaya, O
    Davidson, EA
    Schmerr, MJ
    Orser, CS
    BIOTECHNOLOGY LETTERS, 2005, 27 (09) : 671 - 675
  • [9] Conformational biosensor for diagnosis of prion diseases
    Olga Tcherkasskaya
    Eugene A. Davidson
    Mary Jo Schmerr
    Cindy S. Orser
    Biotechnology Letters, 2005, 27 : 671 - 675
  • [10] Neuropathology of conformational disorders: Sporadic 4R tauopathies
    Dickson, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S48 - S48